Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.42 | N/A |
| PEG Ratio (TTM) | 1.71 | N/A |
| P/S Ratio (TTM) | 1.00 | N/A |
| P/B Ratio (TTM) | 3.32 | N/A |
| P/FCF Ratio (TTM) | 38.86 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.01 | N/A |
| Price to 5YR AVG FCF Ratio | 0.00 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.71% | N/A |
| ROE (TTM) | 15.65% | N/A |
| Net Profit Margin (TTM) | 17.28% | N/A |
| ROIC 5YR AVG | 17.41% | N/A |
Growth (78%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.78% | 322.79% | 220.43% |
| Revenue | 13.10% | 6.31% | 8.92% |
| Net Income | 0.69% | 435.62% | 272.60% |
| Cash Flow | -130.53% | 342.14% | 245.18% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.67 | N/A |
| Interest Coverage (TTM) | -0.30 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.46 | N/A |
| LTL to 5YR AVG FCF | 3.63 | N/A |
| Shares Outstanding Growth 5YR AVG | 60.00% | N/A |